DK0973511T3 - Anvendelse af sibutraminanaloger til at sænke lipidniveauer - Google Patents

Anvendelse af sibutraminanaloger til at sænke lipidniveauer

Info

Publication number
DK0973511T3
DK0973511T3 DK97910289T DK97910289T DK0973511T3 DK 0973511 T3 DK0973511 T3 DK 0973511T3 DK 97910289 T DK97910289 T DK 97910289T DK 97910289 T DK97910289 T DK 97910289T DK 0973511 T3 DK0973511 T3 DK 0973511T3
Authority
DK
Denmark
Prior art keywords
lipid levels
lower lipid
humans
sibutramine
analogues
Prior art date
Application number
DK97910289T
Other languages
Danish (da)
English (en)
Inventor
Finian Kelly Peter
Paul Jones Stephen
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Application granted granted Critical
Publication of DK0973511T3 publication Critical patent/DK0973511T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Fats And Perfumes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Analogue/Digital Conversion (AREA)
DK97910289T 1996-09-25 1997-09-15 Anvendelse af sibutraminanaloger til at sænke lipidniveauer DK0973511T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619961.7A GB9619961D0 (en) 1996-09-25 1996-09-25 Medical treatment
PCT/EP1997/005040 WO1998013034A1 (en) 1996-09-25 1997-09-15 Use of sibutramine analogues to lower lipid levels

Publications (1)

Publication Number Publication Date
DK0973511T3 true DK0973511T3 (da) 2003-08-25

Family

ID=10800447

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97910289T DK0973511T3 (da) 1996-09-25 1997-09-15 Anvendelse af sibutraminanaloger til at sænke lipidniveauer

Country Status (26)

Country Link
US (1) US6187820B1 (de)
EP (1) EP0973511B1 (de)
JP (1) JP4143126B2 (de)
KR (1) KR100573333B1 (de)
CN (1) CN1173696C (de)
AT (1) ATE239459T1 (de)
AU (1) AU724645B2 (de)
BG (1) BG64472B1 (de)
BR (1) BR9711411A (de)
CA (1) CA2266378C (de)
CZ (1) CZ291879B6 (de)
DE (1) DE69721833T2 (de)
DK (1) DK0973511T3 (de)
ES (1) ES2199354T3 (de)
GB (1) GB9619961D0 (de)
HU (1) HU224711B1 (de)
IL (1) IL128820A (de)
NO (1) NO991424D0 (de)
NZ (1) NZ334550A (de)
PL (1) PL190017B1 (de)
PT (1) PT973511E (de)
RU (1) RU2197959C2 (de)
SK (1) SK284282B6 (de)
TR (1) TR199900648T2 (de)
UA (1) UA63916C2 (de)
WO (1) WO1998013034A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331571B1 (en) * 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
AU2007200334B8 (en) * 1998-08-24 2010-10-21 Sepracor, Inc. Methods of using and compositions comprising dopamine reuptake inhibitors
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6046242A (en) * 1998-11-27 2000-04-04 Basf Aktiengesellschaft Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
US6323242B1 (en) 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
US6696495B2 (en) 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
WO2000056308A1 (en) * 1999-03-19 2000-09-28 Knoll Pharmaceutical Company Prevention of cardiovascular disease
US6552087B1 (en) 1999-03-19 2003-04-22 Abbott Gmbh & Co. Kg Therapeutic agent comprising (+)-sibutramine
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
BR0315084A (pt) * 2002-10-05 2005-08-16 Hanmi Pharm Ind Co Ltd Composição farmacêutica compreendendo hemiidrato cristalino de metanossulfonato de sibutramina
WO2004096202A1 (en) * 2003-04-28 2004-11-11 Cipla Limited Pharmaceutical formulation comprising anti-obesity agent and acidulant
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
US20050032908A1 (en) * 2003-08-04 2005-02-10 Beckman Kristen M. Methods for treating metabolic syndrome
KR100618176B1 (ko) 2004-12-02 2006-09-01 휴먼팜 주식회사 시부트라민 주석산염, 이의 제조 방법 및 이를 포함하는약학적 조성물
JP2008526836A (ja) * 2005-01-06 2008-07-24 シージェー チェイルジェダン コーポレーション シブトラミンの無機酸塩
KR20060080817A (ko) 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 디카복실산염
KR20060080818A (ko) * 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 술폰산염
KR20060093564A (ko) * 2005-02-22 2006-08-25 종근당바이오 주식회사 무수 시부트라민 말산염 및 이의 제조 방법
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
KR100814384B1 (ko) * 2006-02-10 2008-03-18 대화제약 주식회사 시부트라민 염을 함유하는 약학 조성물 및 이의 제조방법
US8604244B2 (en) 2010-07-02 2013-12-10 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
JP2010503709A (ja) 2006-09-15 2010-02-04 レビバ ファーマシューティカルズ，インコーポレーテッド シクロアルキルメチルアミンの合成、使用方法および組成物
AU2007322477A1 (en) * 2006-11-22 2008-05-29 Sk Chemicals Co., Ltd. Inclusion complex of sibutramine and beta-cyclodextrin
WO2010082216A2 (en) * 2008-12-08 2010-07-22 Matrix Laboratories Ltd Novel salts of sibutramine and their crystal forms
KR20140110014A (ko) 2011-12-30 2014-09-16 레비바 파마슈티칼스, 아이엔씨. 페닐시클로알킬메틸아민 유도체의 조성물, 합성, 및 사용 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
CZ291879B6 (cs) 2003-06-18
DE69721833T2 (de) 2003-12-24
KR100573333B1 (ko) 2006-04-24
UA63916C2 (uk) 2004-02-16
PL332367A1 (en) 1999-09-13
DE69721833D1 (de) 2003-06-12
RU2197959C2 (ru) 2003-02-10
CN1173696C (zh) 2004-11-03
AU724645B2 (en) 2000-09-28
SK284282B6 (sk) 2004-12-01
US6187820B1 (en) 2001-02-13
CA2266378C (en) 2007-02-13
CZ93299A3 (cs) 2000-07-12
PL190017B1 (pl) 2005-10-31
BG103249A (en) 1999-09-30
IL128820A0 (en) 2000-01-31
ATE239459T1 (de) 2003-05-15
SK32099A3 (en) 1999-12-10
WO1998013034A1 (en) 1998-04-02
NO991424L (no) 1999-03-24
NO991424D0 (no) 1999-03-24
IL128820A (en) 2001-10-31
JP4143126B2 (ja) 2008-09-03
HU224711B1 (en) 2006-01-30
EP0973511A1 (de) 2000-01-26
KR20000048567A (ko) 2000-07-25
JP2001500883A (ja) 2001-01-23
GB9619961D0 (en) 1996-11-13
BG64472B1 (bg) 2005-04-30
HUP9903823A3 (en) 2000-07-28
NZ334550A (en) 2000-09-29
TR199900648T2 (xx) 1999-06-21
CA2266378A1 (en) 1998-04-02
BR9711411A (pt) 1999-08-17
CN1231605A (zh) 1999-10-13
AU4774197A (en) 1998-04-17
ES2199354T3 (es) 2004-02-16
PT973511E (pt) 2003-08-29
HUP9903823A2 (hu) 2000-06-28
EP0973511B1 (de) 2003-05-07

Similar Documents

Publication Publication Date Title
DK0973511T3 (da) Anvendelse af sibutraminanaloger til at sænke lipidniveauer
ATE232720T1 (de) Adjuvans für impfstoff
DK0814788T3 (da) Forbedring af glucosetolerance
ATE468015T1 (de) Etheramin-tenside enthaltende pestizidkonzentrate
MY116150A (en) Use of sibutramine analogues to prevent the development of diabetes
BR0311193A (pt) Aduto de topiramato e cloridrato de tramadol e usos dos mesmos
PT1427280E (pt) Novos compostos
WO2001021608A3 (en) Novel flavonoids
PT1007023E (pt) Derivados de 1-¬1-(4-clorofenil)ciclobutil|-3-metil-butil amina para reducao dos niveis de acido urico em seres humanos
BR0314843A (pt) Novo composto
BR0214742A (pt) Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação
DK1169029T3 (da) Anvendelse af sibutramin eller et derivat deraf til behandling af sövnforstyrrelser
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
BR0107592A (pt) Compostos calcilìticos
DE69827614D1 (de) Chinoxalindionen
UY28111A1 (es) Nueva forma de dosificación oral de liberación inmediata
MXPA01009469A (es) Tratamiento para disminuir la adhesividad de las plaquetas.
WO2003058670A3 (en) A crt having a shadow mask vibration damper
BG105999A (en) Treatment of osteoarthritis
MXPA01009465A (es) Perdida de peso despues del embarazo.
MXPA01009468A (es) Tratamiento de hipertension pulmonar.
MXPA02008957A (es) Depurador de amortiguamiento de mascara de tension para un tubo de rayos catodicos.
RU99124224A (ru) Новые гидрохлориды замещенных ацетиленовых аминоспиртов-активные и низко токсичные антагонисты галоперидола
TR200102700T2 (tr) Karın fıtığının (hiatal hernia) tedavisi.
ITMI20010355V0 (it) Struttura per l'assemblaggio dippanchine e simili.